Document Detail

Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern.
MedLine Citation:
PMID:  15925048     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To investigate the role of endometrial thickness and pattern on the day of human chorionic gonadotropin (hCG) administration on in vitro fertilization (IVF)/intracytoplasmic injection (ICSI) outcome. STUDY DESIGN: A total of 150 infertile women undergoing embryo transfer after IVF/ICSI cycles were studied in a prospective survey. Sonographic features of the endometrium (thickness and pattern) on the day of hCG administration, hormonal profile (progesterone, estradiol, FSH, LH) and various other variables (maternal age, causes and duration of infertility, duration of treatment, number of human menopausal gonadotropin (hMG) ampoules administered, and number of oocytes retrieved) were evaluated. These variables in pregnant and nonpregnant patients were compared. RESULTS: There was no difference between pregnant and nonpregnant patients in mean endometrium thickness (10.1+/-1 versus 10.2+/-2, p=0.79). Pregnancies occurred only in patients with an endometrial thickness of 9-12 mm (p=0.036). Duration of treatment, number of hMG ampoules administered, number of oocytes retrieved, estradiol concentration, and estradiol/progesterone ratio on the day of hCG differed significantly between pregnant and nonpregnant patients. There was no correlation between endometrial pattern and pregnancy rate. The receiver-operating characteristic (ROC) curve and multiple logistic regression showed no significant effect of endometrial thickness in the outcome of IVF/ICSI. CONCLUSION: The sonographic features of the endometrium (thickness and pattern) on the day of hCG administration did not differ between pregnant and nonpregnant patients. The pregnancy rate declined beyond two limits of endometrial thickness.
Batool Hosseini Rashidi; Mandana Sadeghi; Mina Jafarabadi; Ensiyeh Shahrokh Tehrani Nejad
Related Documents :
8213108 - Embryonal reduction using transvaginal saline injection in a sextuplet pregnancy after ...
11821268 - Delivery rates following ivf treatment, using two recombinant fsh preparations for ovar...
20031018 - Live births after management of severe ohss by gnrh antagonist administration in the lu...
1577928 - Intravenous pulsatile administration of gonadotrophins in an in-vitro fertilization pro...
24516548 - Maternal factors associated with fetal growth and birthweight are independent determina...
11003228 - Optimization of dairy heifer management decisions based on production conditions of pen...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  120     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-31     Completed Date:  2005-12-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  179-84     Citation Subset:  IM    
Valiasr Reproductive Health Research Center, Tehran University for Medical Sciences, Infertility Unit, V.R.H.R.C., Imam Khomeini Hospital, Keshavarz Boulevard, Tehran 19378, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chorionic Gonadotropin / administration & dosage
Embryo Transfer
Endometrium / ultrasonography*
Fertilization in Vitro*
Logistic Models
ROC Curve
Sperm Injections, Intracytoplasmic*
Treatment Outcome*
Reg. No./Substance:
0/Chorionic Gonadotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Short stature--an independent risk factor for Cesarean delivery.
Next Document:  A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovaria...